Chemiesynth (Vapi) Ltd held its 40th Annual General Meeting on September 30, 2026, approving a major capital restructuring. The company received shareholder backing to increase its authorized share capital from Rs 3.25 crore to Rs 18.25 crore. Furthermore, the firm secured approval to issue up to Rs 15 crore in 5% Unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) via private placement to bolster its financial position. Investors should monitor future disclosures regarding the actual fund deployment and subscription status.
Chemiesynth (Vapi) Announces Major Capital Restructuring and Fundraising Plan
Authorised share capital raised to Rs 18.25 crore; Rs 15 crore preference share issuance approved.
Reader Takeaway: Strengthening capital base through preference shares; watch for fund utilization and debt servicing capability impact.
What just happened
At its 40th Annual General Meeting held on September 30, 2026, shareholders of Chemiesynth (Vapi) Ltd approved a significant transformation of the company’s capital structure. The primary resolution passed involves increasing the authorised share capital from Rs 3.25 crore to Rs 18.25 crore. This expansion facilitates the issuance of up to Rs 15 crore in 5% Unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) on a private placement basis.
Why this matters
The infusion of Rs 15 crore through NCRPS is a strategic move to optimize the company’s balance sheet. The preference shares carry a 7-year maturity and a 5% cumulative dividend rate, with call/put options available after two years, offering the company flexibility in its long-term financial management. This move provides the necessary capital headroom for the firm's planned activities for the 2026-27 fiscal year.
Related Party Transactions
The company also secured approvals for several related party transactions for FY 2026-27. These include limits of Rs 15 crore for transactions with CS Speciality Chemicals Pvt Ltd, Rs 10 crore with CS Fine Interchem Pvt Ltd, and Rs 10 crore for unsecured loan arrangements with its promoters, Mr. Satish B. Zaveri and Mr. Sandip S. Zaveri.
Governance and Board Updates
As part of the routine business, Mr. Rushabh Mehta was reappointed as a director, subject to retirement-by-rotation provisions. The company maintained standard procedural compliance by appointing Mr. Nitin Sarfare to oversee the voting and polling process, with results to be formally communicated to the exchange.
What to track next
Investors should look for the official declaration of voting results and subsequent announcements detailing the timeline for the private placement of the NCRPS. Tracking the actual drawdown of these funds and how the company utilizes the capital for operational or investment purposes will be crucial for assessing future growth.